English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

A simple approach to a new T8-POSS based MRI contrast agent

MPS-Authors
/persons/resource/persons83903

Engelmann,  J
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

/persons/resource/persons84187

Scheffler,  K
Max Planck Institute for Biological Cybernetics, Max Planck Society;
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

Link
(Any fulltext)

Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Strauch, H., Engelmann, J., Scheffler, K., & Mayer, H. (2016). A simple approach to a new T8-POSS based MRI contrast agent. Dalton Transactions, 45(38), 15104-15113. doi:10.1039/C6DT02365G.


Cite as: http://hdl.handle.net/21.11116/0000-0000-7971-9
Abstract
A fast and simple route was developed to synthesize a new T8-silsesquioxane based contrast agent for potential application in Magnetic Resonance Imaging. For this purpose the novel C2-thiol-functionalized T8-silsesquioxane (3) was constructed as a carrier molecule as well as the DOTA based gadolinium(III) complex (11) equipped with allyl terminated linkers was prepared. The linkage of the complexes to the T8-silsesquioxane was performed via an UV-light catalyzed thiol–ene click reaction within one hour which affords the desired product 13 in a yield of 80. The successful transformation as well as the intactness of the cube was confirmed by spectroscopic methods and mass spectrometry. This new and simple approach offers a highly effective access to T8-silsesquioxanes functionalized with eight metal complexes. Longitudinal relaxivity measurements of compound 13 (9.5 ± 0.9 mM−1 s−1) at 3 T in HEPES buffered cell culture medium (physiological conditions) show a significant enhancement of r1 per 1 mM gadolinium in comparison to the clinically applied contrast agent Dotarem™ (3.4 mM−1 s−1). In relation to the former reported T8-silsesquioxane based contrast agent Gadoxane G (10.6 mM−1 s−1) a similar relaxivity is found. As the T8-core of polyhedral oligosilsesquioxanes (POSS) based contrast agents undergoes a hydrolysis process depending on the pH, long-term r1 measurements in different solutions (water, cell culture medium and HEPES buffered medium) as well as 1H, 1H/29Si HSQC and PGSE diffusion 1H NMR spectroscopic investigations on aqueous solutions were performed. In solutions featuring an approximately neutral pH (D2O, pD = 7.0; water and HEPES buffered medium, pH = 7.4–7.5) contrast agent 13 (t1/2 = 2.4 d, HEPES/medium) shows a slower decomposition of the T8-cage in comparison to the previously synthesized Gadoxane G (t1/2 = 15 ± 3 h, HEPES/medium). However, under more basic conditions (medium, pH = 8.4–8.5) the decomposition process of 13 is considerably accelerated (t1/2 ∼ 55–60 min), indicating a higher sensitivity of the T8-cage to pH shifts into the basic range similar to Gadoxane G.